SUBSCRIBE
SUBSCRIBE
News   Deals

SenoRx, Inc. Files For $86.25 Million IPO

May 26, 2006 | 
1 min read
WASHINGTON, May 25 (Reuters) - SenoRx Inc., which makes medical devices for diagnosing and treating breast cancer, on Thursday said it is planning an initial public offering for up to $86.25 million in common stock.
IPO
MORE ON THIS TOPIC
3d fatty liver disease isolated on pink background. 3d illustration render
MASH
Madrigal Dives Further Into MASH With up to $4.4B siRNA Deal With Chinese Biotech
February 11, 2026
 · 
2 min read
 · 
Tristan Manalac
Podcast
Weight Loss Drama Compounds on Heels of Novo, Lilly Earnings, Plus Gene Therapy News
February 11, 2026
 · 
1 min read
 · 
Jef Akst
Creativity and new ideas in business. Art collage.
Mergers & acquisitions
Eli Lilly Enters CAR T Realm With $2.4B Orna Buy, Starting With Autoimmune
February 9, 2026
 · 
2 min read
 · 
Dan Samorodnitsky
IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch
IPO
Eikon Clocks Largest IPO Since 2024, Generate, AgomAb Follow
February 6, 2026
 · 
5 min read
 · 
Tristan Manalac